Global Personalized Cell Therapeutic Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Page: 129
Published Date: 10 Jan 2024
Category: Medical Care
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Personalized Cell Therapeutic market size was valued at USD 12940 million in 2023 and is forecast to a readjusted size of USD 26070 million by 2030 with a CAGR of 10.5% during review period.
Personalized cells are undifferentiated stem cells that can be divided to generate offspring cells designated as specialized or personalized stem cells. Specialized treatment of numerous chronic diseases such as autoimmune and cancer through vaccinating living cells into the body of patients to boost the personalized cell therapy market. As there are multiple types of living cells such as immature and mature living cell, blood and bone marrow cell and embryonic stem cells that are mainly utilized in personalized cell therapy.
Several manufacturers are conducting numerous clinical trials to develop new personalized cell therapies for chronic diseases such as cancer, diabetes and other autoimmune diseases. For example, in April 2019, Orgenesis Inc. received approval from the Institutional Review Board (IRB) to collect liver biopsy samples from patients at the Rambam Medical Center in Israel. Samples were collected to confirm the safety and efficacy of hepatocytes for individualized cell replacement therapy in patients with insulin-dependent diabetes mellitus following total or partial pancreatectomy. Hence, increasing number of studies is expected to boost the growth of the global personalized cell therapy market.
The Global Info Research report includes an overview of the development of the Personalized Cell Therapeutic industry chain, the market status of Cardiovascular Diseases (Embryonic Stem Cells, Adult Stem Cell), Neurological Disorders (Embryonic Stem Cells, Adult Stem Cell), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Personalized Cell Therapeutic.
Regionally, the report analyzes the Personalized Cell Therapeutic markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Personalized Cell Therapeutic market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Personalized Cell Therapeutic market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Personalized Cell Therapeutic industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Embryonic Stem Cells, Adult Stem Cell).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Personalized Cell Therapeutic market.
Regional Analysis: The report involves examining the Personalized Cell Therapeutic market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Personalized Cell Therapeutic market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Personalized Cell Therapeutic:
Company Analysis: Report covers individual Personalized Cell Therapeutic manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Personalized Cell Therapeutic This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Cardiovascular Diseases, Neurological Disorders).
Technology Analysis: Report covers specific technologies relevant to Personalized Cell Therapeutic. It assesses the current state, advancements, and potential future developments in Personalized Cell Therapeutic areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Personalized Cell Therapeutic market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Personalized Cell Therapeutic market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Embryonic Stem Cells
Adult Stem Cell
Induced Pluripotent Cells
Other
Market segment by Application
Cardiovascular Diseases
Neurological Disorders
Diabetes
Oncology
Other
Major players covered
AbbVie Inc
Bausch Health Companies Inc
Teva Pharmaceutical Industries Ltd
Cipla
Lupin
Sun Pharmaceuticals Industries Ltd
Hikma Pharmaceuticals PLC
AstraZeneca
GSK Plc
Pfizer Inc
Amneal Pharmaceuticals LLC
Alvogen
F. Hoffmann-La Roche Ltd
Amgen Inc
Jazz Pharmaceuticals, Inc
Amicus Therapeutics, Inc
MeiraGTx Limited
Rocket Pharmaceuticals, Inc
Gilead Sciences, Inc
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Personalized Cell Therapeutic product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Personalized Cell Therapeutic, with price, sales, revenue and global market share of Personalized Cell Therapeutic from 2019 to 2024.
Chapter 3, the Personalized Cell Therapeutic competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Personalized Cell Therapeutic breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Personalized Cell Therapeutic market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Personalized Cell Therapeutic.
Chapter 14 and 15, to describe Personalized Cell Therapeutic sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Personalized Cell Therapeutic
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Personalized Cell Therapeutic Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Embryonic Stem Cells
1.3.3 Adult Stem Cell
1.3.4 Induced Pluripotent Cells
1.3.5 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Personalized Cell Therapeutic Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Cardiovascular Diseases
1.4.3 Neurological Disorders
1.4.4 Diabetes
1.4.5 Oncology
1.4.6 Other
1.5 Global Personalized Cell Therapeutic Market Size & Forecast
1.5.1 Global Personalized Cell Therapeutic Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Personalized Cell Therapeutic Sales Quantity (2019-2030)
1.5.3 Global Personalized Cell Therapeutic Average Price (2019-2030)
2.1 AbbVie Inc
2.1.1 AbbVie Inc Details
2.1.2 AbbVie Inc Major Business
2.1.3 AbbVie Inc Personalized Cell Therapeutic Product and Services
2.1.4 AbbVie Inc Personalized Cell Therapeutic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 AbbVie Inc Recent Developments/Updates
2.2 Bausch Health Companies Inc
2.2.1 Bausch Health Companies Inc Details
2.2.2 Bausch Health Companies Inc Major Business
2.2.3 Bausch Health Companies Inc Personalized Cell Therapeutic Product and Services
2.2.4 Bausch Health Companies Inc Personalized Cell Therapeutic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Bausch Health Companies Inc Recent Developments/Updates
2.3 Teva Pharmaceutical Industries Ltd
2.3.1 Teva Pharmaceutical Industries Ltd Details
2.3.2 Teva Pharmaceutical Industries Ltd Major Business
2.3.3 Teva Pharmaceutical Industries Ltd Personalized Cell Therapeutic Product and Services
2.3.4 Teva Pharmaceutical Industries Ltd Personalized Cell Therapeutic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
2.4 Cipla
2.4.1 Cipla Details
2.4.2 Cipla Major Business
2.4.3 Cipla Personalized Cell Therapeutic Product and Services
2.4.4 Cipla Personalized Cell Therapeutic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Cipla Recent Developments/Updates
2.5 Lupin
2.5.1 Lupin Details
2.5.2 Lupin Major Business
2.5.3 Lupin Personalized Cell Therapeutic Product and Services
2.5.4 Lupin Personalized Cell Therapeutic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Lupin Recent Developments/Updates
2.6 Sun Pharmaceuticals Industries Ltd
2.6.1 Sun Pharmaceuticals Industries Ltd Details
2.6.2 Sun Pharmaceuticals Industries Ltd Major Business
2.6.3 Sun Pharmaceuticals Industries Ltd Personalized Cell Therapeutic Product and Services
2.6.4 Sun Pharmaceuticals Industries Ltd Personalized Cell Therapeutic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Sun Pharmaceuticals Industries Ltd Recent Developments/Updates
2.7 Hikma Pharmaceuticals PLC
2.7.1 Hikma Pharmaceuticals PLC Details
2.7.2 Hikma Pharmaceuticals PLC Major Business
2.7.3 Hikma Pharmaceuticals PLC Personalized Cell Therapeutic Product and Services
2.7.4 Hikma Pharmaceuticals PLC Personalized Cell Therapeutic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Hikma Pharmaceuticals PLC Recent Developments/Updates
2.8 AstraZeneca
2.8.1 AstraZeneca Details
2.8.2 AstraZeneca Major Business
2.8.3 AstraZeneca Personalized Cell Therapeutic Product and Services
2.8.4 AstraZeneca Personalized Cell Therapeutic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 AstraZeneca Recent Developments/Updates
2.9 GSK Plc
2.9.1 GSK Plc Details
2.9.2 GSK Plc Major Business
2.9.3 GSK Plc Personalized Cell Therapeutic Product and Services
2.9.4 GSK Plc Personalized Cell Therapeutic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 GSK Plc Recent Developments/Updates
2.10 Pfizer Inc
2.10.1 Pfizer Inc Details
2.10.2 Pfizer Inc Major Business
2.10.3 Pfizer Inc Personalized Cell Therapeutic Product and Services
2.10.4 Pfizer Inc Personalized Cell Therapeutic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Pfizer Inc Recent Developments/Updates
2.11 Amneal Pharmaceuticals LLC
2.11.1 Amneal Pharmaceuticals LLC Details
2.11.2 Amneal Pharmaceuticals LLC Major Business
2.11.3 Amneal Pharmaceuticals LLC Personalized Cell Therapeutic Product and Services
2.11.4 Amneal Pharmaceuticals LLC Personalized Cell Therapeutic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Amneal Pharmaceuticals LLC Recent Developments/Updates
2.12 Alvogen
2.12.1 Alvogen Details
2.12.2 Alvogen Major Business
2.12.3 Alvogen Personalized Cell Therapeutic Product and Services
2.12.4 Alvogen Personalized Cell Therapeutic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Alvogen Recent Developments/Updates
2.13 F. Hoffmann-La Roche Ltd
2.13.1 F. Hoffmann-La Roche Ltd Details
2.13.2 F. Hoffmann-La Roche Ltd Major Business
2.13.3 F. Hoffmann-La Roche Ltd Personalized Cell Therapeutic Product and Services
2.13.4 F. Hoffmann-La Roche Ltd Personalized Cell Therapeutic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 F. Hoffmann-La Roche Ltd Recent Developments/Updates
2.14 Amgen Inc
2.14.1 Amgen Inc Details
2.14.2 Amgen Inc Major Business
2.14.3 Amgen Inc Personalized Cell Therapeutic Product and Services
2.14.4 Amgen Inc Personalized Cell Therapeutic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Amgen Inc Recent Developments/Updates
2.15 Jazz Pharmaceuticals, Inc
2.15.1 Jazz Pharmaceuticals, Inc Details
2.15.2 Jazz Pharmaceuticals, Inc Major Business
2.15.3 Jazz Pharmaceuticals, Inc Personalized Cell Therapeutic Product and Services
2.15.4 Jazz Pharmaceuticals, Inc Personalized Cell Therapeutic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Jazz Pharmaceuticals, Inc Recent Developments/Updates
2.16 Amicus Therapeutics, Inc
2.16.1 Amicus Therapeutics, Inc Details
2.16.2 Amicus Therapeutics, Inc Major Business
2.16.3 Amicus Therapeutics, Inc Personalized Cell Therapeutic Product and Services
2.16.4 Amicus Therapeutics, Inc Personalized Cell Therapeutic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Amicus Therapeutics, Inc Recent Developments/Updates
2.17 MeiraGTx Limited
2.17.1 MeiraGTx Limited Details
2.17.2 MeiraGTx Limited Major Business
2.17.3 MeiraGTx Limited Personalized Cell Therapeutic Product and Services
2.17.4 MeiraGTx Limited Personalized Cell Therapeutic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 MeiraGTx Limited Recent Developments/Updates
2.18 Rocket Pharmaceuticals, Inc
2.18.1 Rocket Pharmaceuticals, Inc Details
2.18.2 Rocket Pharmaceuticals, Inc Major Business
2.18.3 Rocket Pharmaceuticals, Inc Personalized Cell Therapeutic Product and Services
2.18.4 Rocket Pharmaceuticals, Inc Personalized Cell Therapeutic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Rocket Pharmaceuticals, Inc Recent Developments/Updates
2.19 Gilead Sciences, Inc
2.19.1 Gilead Sciences, Inc Details
2.19.2 Gilead Sciences, Inc Major Business
2.19.3 Gilead Sciences, Inc Personalized Cell Therapeutic Product and Services
2.19.4 Gilead Sciences, Inc Personalized Cell Therapeutic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Gilead Sciences, Inc Recent Developments/Updates
3.1 Global Personalized Cell Therapeutic Sales Quantity by Manufacturer (2019-2024)
3.2 Global Personalized Cell Therapeutic Revenue by Manufacturer (2019-2024)
3.3 Global Personalized Cell Therapeutic Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Personalized Cell Therapeutic by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Personalized Cell Therapeutic Manufacturer Market Share in 2023
3.4.2 Top 6 Personalized Cell Therapeutic Manufacturer Market Share in 2023
3.5 Personalized Cell Therapeutic Market: Overall Company Footprint Analysis
3.5.1 Personalized Cell Therapeutic Market: Region Footprint
3.5.2 Personalized Cell Therapeutic Market: Company Product Type Footprint
3.5.3 Personalized Cell Therapeutic Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Personalized Cell Therapeutic Market Size by Region
4.1.1 Global Personalized Cell Therapeutic Sales Quantity by Region (2019-2030)
4.1.2 Global Personalized Cell Therapeutic Consumption Value by Region (2019-2030)
4.1.3 Global Personalized Cell Therapeutic Average Price by Region (2019-2030)
4.2 North America Personalized Cell Therapeutic Consumption Value (2019-2030)
4.3 Europe Personalized Cell Therapeutic Consumption Value (2019-2030)
4.4 Asia-Pacific Personalized Cell Therapeutic Consumption Value (2019-2030)
4.5 South America Personalized Cell Therapeutic Consumption Value (2019-2030)
4.6 Middle East and Africa Personalized Cell Therapeutic Consumption Value (2019-2030)
5.1 Global Personalized Cell Therapeutic Sales Quantity by Type (2019-2030)
5.2 Global Personalized Cell Therapeutic Consumption Value by Type (2019-2030)
5.3 Global Personalized Cell Therapeutic Average Price by Type (2019-2030)
6.1 Global Personalized Cell Therapeutic Sales Quantity by Application (2019-2030)
6.2 Global Personalized Cell Therapeutic Consumption Value by Application (2019-2030)
6.3 Global Personalized Cell Therapeutic Average Price by Application (2019-2030)
7.1 North America Personalized Cell Therapeutic Sales Quantity by Type (2019-2030)
7.2 North America Personalized Cell Therapeutic Sales Quantity by Application (2019-2030)
7.3 North America Personalized Cell Therapeutic Market Size by Country
7.3.1 North America Personalized Cell Therapeutic Sales Quantity by Country (2019-2030)
7.3.2 North America Personalized Cell Therapeutic Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8.1 Europe Personalized Cell Therapeutic Sales Quantity by Type (2019-2030)
8.2 Europe Personalized Cell Therapeutic Sales Quantity by Application (2019-2030)
8.3 Europe Personalized Cell Therapeutic Market Size by Country
8.3.1 Europe Personalized Cell Therapeutic Sales Quantity by Country (2019-2030)
8.3.2 Europe Personalized Cell Therapeutic Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9.1 Asia-Pacific Personalized Cell Therapeutic Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Personalized Cell Therapeutic Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Personalized Cell Therapeutic Market Size by Region
9.3.1 Asia-Pacific Personalized Cell Therapeutic Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Personalized Cell Therapeutic Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10.1 South America Personalized Cell Therapeutic Sales Quantity by Type (2019-2030)
10.2 South America Personalized Cell Therapeutic Sales Quantity by Application (2019-2030)
10.3 South America Personalized Cell Therapeutic Market Size by Country
10.3.1 South America Personalized Cell Therapeutic Sales Quantity by Country (2019-2030)
10.3.2 South America Personalized Cell Therapeutic Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11.1 Middle East & Africa Personalized Cell Therapeutic Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Personalized Cell Therapeutic Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Personalized Cell Therapeutic Market Size by Country
11.3.1 Middle East & Africa Personalized Cell Therapeutic Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Personalized Cell Therapeutic Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12.1 Personalized Cell Therapeutic Market Drivers
12.2 Personalized Cell Therapeutic Market Restraints
12.3 Personalized Cell Therapeutic Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13.1 Raw Material of Personalized Cell Therapeutic and Key Manufacturers
13.2 Manufacturing Costs Percentage of Personalized Cell Therapeutic
13.3 Personalized Cell Therapeutic Production Process
13.4 Personalized Cell Therapeutic Industrial Chain
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Personalized Cell Therapeutic Typical Distributors
14.3 Personalized Cell Therapeutic Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Personalized Cell Therapeutic Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Personalized Cell Therapeutic Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. AbbVie Inc Basic Information, Manufacturing Base and Competitors
Table 4. AbbVie Inc Major Business
Table 5. AbbVie Inc Personalized Cell Therapeutic Product and Services
Table 6. AbbVie Inc Personalized Cell Therapeutic Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. AbbVie Inc Recent Developments/Updates
Table 8. Bausch Health Companies Inc Basic Information, Manufacturing Base and Competitors
Table 9. Bausch Health Companies Inc Major Business
Table 10. Bausch Health Companies Inc Personalized Cell Therapeutic Product and Services
Table 11. Bausch Health Companies Inc Personalized Cell Therapeutic Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Bausch Health Companies Inc Recent Developments/Updates
Table 13. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 14. Teva Pharmaceutical Industries Ltd Major Business
Table 15. Teva Pharmaceutical Industries Ltd Personalized Cell Therapeutic Product and Services
Table 16. Teva Pharmaceutical Industries Ltd Personalized Cell Therapeutic Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 18. Cipla Basic Information, Manufacturing Base and Competitors
Table 19. Cipla Major Business
Table 20. Cipla Personalized Cell Therapeutic Product and Services
Table 21. Cipla Personalized Cell Therapeutic Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Cipla Recent Developments/Updates
Table 23. Lupin Basic Information, Manufacturing Base and Competitors
Table 24. Lupin Major Business
Table 25. Lupin Personalized Cell Therapeutic Product and Services
Table 26. Lupin Personalized Cell Therapeutic Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Lupin Recent Developments/Updates
Table 28. Sun Pharmaceuticals Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 29. Sun Pharmaceuticals Industries Ltd Major Business
Table 30. Sun Pharmaceuticals Industries Ltd Personalized Cell Therapeutic Product and Services
Table 31. Sun Pharmaceuticals Industries Ltd Personalized Cell Therapeutic Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Sun Pharmaceuticals Industries Ltd Recent Developments/Updates
Table 33. Hikma Pharmaceuticals PLC Basic Information, Manufacturing Base and Competitors
Table 34. Hikma Pharmaceuticals PLC Major Business
Table 35. Hikma Pharmaceuticals PLC Personalized Cell Therapeutic Product and Services
Table 36. Hikma Pharmaceuticals PLC Personalized Cell Therapeutic Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Hikma Pharmaceuticals PLC Recent Developments/Updates
Table 38. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 39. AstraZeneca Major Business
Table 40. AstraZeneca Personalized Cell Therapeutic Product and Services
Table 41. AstraZeneca Personalized Cell Therapeutic Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. AstraZeneca Recent Developments/Updates
Table 43. GSK Plc Basic Information, Manufacturing Base and Competitors
Table 44. GSK Plc Major Business
Table 45. GSK Plc Personalized Cell Therapeutic Product and Services
Table 46. GSK Plc Personalized Cell Therapeutic Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. GSK Plc Recent Developments/Updates
Table 48. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 49. Pfizer Inc Major Business
Table 50. Pfizer Inc Personalized Cell Therapeutic Product and Services
Table 51. Pfizer Inc Personalized Cell Therapeutic Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Pfizer Inc Recent Developments/Updates
Table 53. Amneal Pharmaceuticals LLC Basic Information, Manufacturing Base and Competitors
Table 54. Amneal Pharmaceuticals LLC Major Business
Table 55. Amneal Pharmaceuticals LLC Personalized Cell Therapeutic Product and Services
Table 56. Amneal Pharmaceuticals LLC Personalized Cell Therapeutic Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Amneal Pharmaceuticals LLC Recent Developments/Updates
Table 58. Alvogen Basic Information, Manufacturing Base and Competitors
Table 59. Alvogen Major Business
Table 60. Alvogen Personalized Cell Therapeutic Product and Services
Table 61. Alvogen Personalized Cell Therapeutic Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Alvogen Recent Developments/Updates
Table 63. F. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table 64. F. Hoffmann-La Roche Ltd Major Business
Table 65. F. Hoffmann-La Roche Ltd Personalized Cell Therapeutic Product and Services
Table 66. F. Hoffmann-La Roche Ltd Personalized Cell Therapeutic Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. F. Hoffmann-La Roche Ltd Recent Developments/Updates
Table 68. Amgen Inc Basic Information, Manufacturing Base and Competitors
Table 69. Amgen Inc Major Business
Table 70. Amgen Inc Personalized Cell Therapeutic Product and Services
Table 71. Amgen Inc Personalized Cell Therapeutic Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. Amgen Inc Recent Developments/Updates
Table 73. Jazz Pharmaceuticals, Inc Basic Information, Manufacturing Base and Competitors
Table 74. Jazz Pharmaceuticals, Inc Major Business
Table 75. Jazz Pharmaceuticals, Inc Personalized Cell Therapeutic Product and Services
Table 76. Jazz Pharmaceuticals, Inc Personalized Cell Therapeutic Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Jazz Pharmaceuticals, Inc Recent Developments/Updates
Table 78. Amicus Therapeutics, Inc Basic Information, Manufacturing Base and Competitors
Table 79. Amicus Therapeutics, Inc Major Business
Table 80. Amicus Therapeutics, Inc Personalized Cell Therapeutic Product and Services
Table 81. Amicus Therapeutics, Inc Personalized Cell Therapeutic Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 82. Amicus Therapeutics, Inc Recent Developments/Updates
Table 83. MeiraGTx Limited Basic Information, Manufacturing Base and Competitors
Table 84. MeiraGTx Limited Major Business
Table 85. MeiraGTx Limited Personalized Cell Therapeutic Product and Services
Table 86. MeiraGTx Limited Personalized Cell Therapeutic Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 87. MeiraGTx Limited Recent Developments/Updates
Table 88. Rocket Pharmaceuticals, Inc Basic Information, Manufacturing Base and Competitors
Table 89. Rocket Pharmaceuticals, Inc Major Business
Table 90. Rocket Pharmaceuticals, Inc Personalized Cell Therapeutic Product and Services
Table 91. Rocket Pharmaceuticals, Inc Personalized Cell Therapeutic Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 92. Rocket Pharmaceuticals, Inc Recent Developments/Updates
Table 93. Gilead Sciences, Inc Basic Information, Manufacturing Base and Competitors
Table 94. Gilead Sciences, Inc Major Business
Table 95. Gilead Sciences, Inc Personalized Cell Therapeutic Product and Services
Table 96. Gilead Sciences, Inc Personalized Cell Therapeutic Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 97. Gilead Sciences, Inc Recent Developments/Updates
Table 98. Global Personalized Cell Therapeutic Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 99. Global Personalized Cell Therapeutic Revenue by Manufacturer (2019-2024) & (USD Million)
Table 100. Global Personalized Cell Therapeutic Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 101. Market Position of Manufacturers in Personalized Cell Therapeutic, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 102. Head Office and Personalized Cell Therapeutic Production Site of Key Manufacturer
Table 103. Personalized Cell Therapeutic Market: Company Product Type Footprint
Table 104. Personalized Cell Therapeutic Market: Company Product Application Footprint
Table 105. Personalized Cell Therapeutic New Market Entrants and Barriers to Market Entry
Table 106. Personalized Cell Therapeutic Mergers, Acquisition, Agreements, and Collaborations
Table 107. Global Personalized Cell Therapeutic Sales Quantity by Region (2019-2024) & (K Units)
Table 108. Global Personalized Cell Therapeutic Sales Quantity by Region (2025-2030) & (K Units)
Table 109. Global Personalized Cell Therapeutic Consumption Value by Region (2019-2024) & (USD Million)
Table 110. Global Personalized Cell Therapeutic Consumption Value by Region (2025-2030) & (USD Million)
Table 111. Global Personalized Cell Therapeutic Average Price by Region (2019-2024) & (US$/Unit)
Table 112. Global Personalized Cell Therapeutic Average Price by Region (2025-2030) & (US$/Unit)
Table 113. Global Personalized Cell Therapeutic Sales Quantity by Type (2019-2024) & (K Units)
Table 114. Global Personalized Cell Therapeutic Sales Quantity by Type (2025-2030) & (K Units)
Table 115. Global Personalized Cell Therapeutic Consumption Value by Type (2019-2024) & (USD Million)
Table 116. Global Personalized Cell Therapeutic Consumption Value by Type (2025-2030) & (USD Million)
Table 117. Global Personalized Cell Therapeutic Average Price by Type (2019-2024) & (US$/Unit)
Table 118. Global Personalized Cell Therapeutic Average Price by Type (2025-2030) & (US$/Unit)
Table 119. Global Personalized Cell Therapeutic Sales Quantity by Application (2019-2024) & (K Units)
Table 120. Global Personalized Cell Therapeutic Sales Quantity by Application (2025-2030) & (K Units)
Table 121. Global Personalized Cell Therapeutic Consumption Value by Application (2019-2024) & (USD Million)
Table 122. Global Personalized Cell Therapeutic Consumption Value by Application (2025-2030) & (USD Million)
Table 123. Global Personalized Cell Therapeutic Average Price by Application (2019-2024) & (US$/Unit)
Table 124. Global Personalized Cell Therapeutic Average Price by Application (2025-2030) & (US$/Unit)
Table 125. North America Personalized Cell Therapeutic Sales Quantity by Type (2019-2024) & (K Units)
Table 126. North America Personalized Cell Therapeutic Sales Quantity by Type (2025-2030) & (K Units)
Table 127. North America Personalized Cell Therapeutic Sales Quantity by Application (2019-2024) & (K Units)
Table 128. North America Personalized Cell Therapeutic Sales Quantity by Application (2025-2030) & (K Units)
Table 129. North America Personalized Cell Therapeutic Sales Quantity by Country (2019-2024) & (K Units)
Table 130. North America Personalized Cell Therapeutic Sales Quantity by Country (2025-2030) & (K Units)
Table 131. North America Personalized Cell Therapeutic Consumption Value by Country (2019-2024) & (USD Million)
Table 132. North America Personalized Cell Therapeutic Consumption Value by Country (2025-2030) & (USD Million)
Table 133. Europe Personalized Cell Therapeutic Sales Quantity by Type (2019-2024) & (K Units)
Table 134. Europe Personalized Cell Therapeutic Sales Quantity by Type (2025-2030) & (K Units)
Table 135. Europe Personalized Cell Therapeutic Sales Quantity by Application (2019-2024) & (K Units)
Table 136. Europe Personalized Cell Therapeutic Sales Quantity by Application (2025-2030) & (K Units)
Table 137. Europe Personalized Cell Therapeutic Sales Quantity by Country (2019-2024) & (K Units)
Table 138. Europe Personalized Cell Therapeutic Sales Quantity by Country (2025-2030) & (K Units)
Table 139. Europe Personalized Cell Therapeutic Consumption Value by Country (2019-2024) & (USD Million)
Table 140. Europe Personalized Cell Therapeutic Consumption Value by Country (2025-2030) & (USD Million)
Table 141. Asia-Pacific Personalized Cell Therapeutic Sales Quantity by Type (2019-2024) & (K Units)
Table 142. Asia-Pacific Personalized Cell Therapeutic Sales Quantity by Type (2025-2030) & (K Units)
Table 143. Asia-Pacific Personalized Cell Therapeutic Sales Quantity by Application (2019-2024) & (K Units)
Table 144. Asia-Pacific Personalized Cell Therapeutic Sales Quantity by Application (2025-2030) & (K Units)
Table 145. Asia-Pacific Personalized Cell Therapeutic Sales Quantity by Region (2019-2024) & (K Units)
Table 146. Asia-Pacific Personalized Cell Therapeutic Sales Quantity by Region (2025-2030) & (K Units)
Table 147. Asia-Pacific Personalized Cell Therapeutic Consumption Value by Region (2019-2024) & (USD Million)
Table 148. Asia-Pacific Personalized Cell Therapeutic Consumption Value by Region (2025-2030) & (USD Million)
Table 149. South America Personalized Cell Therapeutic Sales Quantity by Type (2019-2024) & (K Units)
Table 150. South America Personalized Cell Therapeutic Sales Quantity by Type (2025-2030) & (K Units)
Table 151. South America Personalized Cell Therapeutic Sales Quantity by Application (2019-2024) & (K Units)
Table 152. South America Personalized Cell Therapeutic Sales Quantity by Application (2025-2030) & (K Units)
Table 153. South America Personalized Cell Therapeutic Sales Quantity by Country (2019-2024) & (K Units)
Table 154. South America Personalized Cell Therapeutic Sales Quantity by Country (2025-2030) & (K Units)
Table 155. South America Personalized Cell Therapeutic Consumption Value by Country (2019-2024) & (USD Million)
Table 156. South America Personalized Cell Therapeutic Consumption Value by Country (2025-2030) & (USD Million)
Table 157. Middle East & Africa Personalized Cell Therapeutic Sales Quantity by Type (2019-2024) & (K Units)
Table 158. Middle East & Africa Personalized Cell Therapeutic Sales Quantity by Type (2025-2030) & (K Units)
Table 159. Middle East & Africa Personalized Cell Therapeutic Sales Quantity by Application (2019-2024) & (K Units)
Table 160. Middle East & Africa Personalized Cell Therapeutic Sales Quantity by Application (2025-2030) & (K Units)
Table 161. Middle East & Africa Personalized Cell Therapeutic Sales Quantity by Region (2019-2024) & (K Units)
Table 162. Middle East & Africa Personalized Cell Therapeutic Sales Quantity by Region (2025-2030) & (K Units)
Table 163. Middle East & Africa Personalized Cell Therapeutic Consumption Value by Region (2019-2024) & (USD Million)
Table 164. Middle East & Africa Personalized Cell Therapeutic Consumption Value by Region (2025-2030) & (USD Million)
Table 165. Personalized Cell Therapeutic Raw Material
Table 166. Key Manufacturers of Personalized Cell Therapeutic Raw Materials
Table 167. Personalized Cell Therapeutic Typical Distributors
Table 168. Personalized Cell Therapeutic Typical Customers
List of Figures
Figure 1. Personalized Cell Therapeutic Picture
Figure 2. Global Personalized Cell Therapeutic Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Personalized Cell Therapeutic Consumption Value Market Share by Type in 2023
Figure 4. Embryonic Stem Cells Examples
Figure 5. Adult Stem Cell Examples
Figure 6. Induced Pluripotent Cells Examples
Figure 7. Other Examples
Figure 8. Global Personalized Cell Therapeutic Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 9. Global Personalized Cell Therapeutic Consumption Value Market Share by Application in 2023
Figure 10. Cardiovascular Diseases Examples
Figure 11. Neurological Disorders Examples
Figure 12. Diabetes Examples
Figure 13. Oncology Examples
Figure 14. Other Examples
Figure 15. Global Personalized Cell Therapeutic Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 16. Global Personalized Cell Therapeutic Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 17. Global Personalized Cell Therapeutic Sales Quantity (2019-2030) & (K Units)
Figure 18. Global Personalized Cell Therapeutic Average Price (2019-2030) & (US$/Unit)
Figure 19. Global Personalized Cell Therapeutic Sales Quantity Market Share by Manufacturer in 2023
Figure 20. Global Personalized Cell Therapeutic Consumption Value Market Share by Manufacturer in 2023
Figure 21. Producer Shipments of Personalized Cell Therapeutic by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 22. Top 3 Personalized Cell Therapeutic Manufacturer (Consumption Value) Market Share in 2023
Figure 23. Top 6 Personalized Cell Therapeutic Manufacturer (Consumption Value) Market Share in 2023
Figure 24. Global Personalized Cell Therapeutic Sales Quantity Market Share by Region (2019-2030)
Figure 25. Global Personalized Cell Therapeutic Consumption Value Market Share by Region (2019-2030)
Figure 26. North America Personalized Cell Therapeutic Consumption Value (2019-2030) & (USD Million)
Figure 27. Europe Personalized Cell Therapeutic Consumption Value (2019-2030) & (USD Million)
Figure 28. Asia-Pacific Personalized Cell Therapeutic Consumption Value (2019-2030) & (USD Million)
Figure 29. South America Personalized Cell Therapeutic Consumption Value (2019-2030) & (USD Million)
Figure 30. Middle East & Africa Personalized Cell Therapeutic Consumption Value (2019-2030) & (USD Million)
Figure 31. Global Personalized Cell Therapeutic Sales Quantity Market Share by Type (2019-2030)
Figure 32. Global Personalized Cell Therapeutic Consumption Value Market Share by Type (2019-2030)
Figure 33. Global Personalized Cell Therapeutic Average Price by Type (2019-2030) & (US$/Unit)
Figure 34. Global Personalized Cell Therapeutic Sales Quantity Market Share by Application (2019-2030)
Figure 35. Global Personalized Cell Therapeutic Consumption Value Market Share by Application (2019-2030)
Figure 36. Global Personalized Cell Therapeutic Average Price by Application (2019-2030) & (US$/Unit)
Figure 37. North America Personalized Cell Therapeutic Sales Quantity Market Share by Type (2019-2030)
Figure 38. North America Personalized Cell Therapeutic Sales Quantity Market Share by Application (2019-2030)
Figure 39. North America Personalized Cell Therapeutic Sales Quantity Market Share by Country (2019-2030)
Figure 40. North America Personalized Cell Therapeutic Consumption Value Market Share by Country (2019-2030)
Figure 41. United States Personalized Cell Therapeutic Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Canada Personalized Cell Therapeutic Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 43. Mexico Personalized Cell Therapeutic Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. Europe Personalized Cell Therapeutic Sales Quantity Market Share by Type (2019-2030)
Figure 45. Europe Personalized Cell Therapeutic Sales Quantity Market Share by Application (2019-2030)
Figure 46. Europe Personalized Cell Therapeutic Sales Quantity Market Share by Country (2019-2030)
Figure 47. Europe Personalized Cell Therapeutic Consumption Value Market Share by Country (2019-2030)
Figure 48. Germany Personalized Cell Therapeutic Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. France Personalized Cell Therapeutic Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. United Kingdom Personalized Cell Therapeutic Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Russia Personalized Cell Therapeutic Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. Italy Personalized Cell Therapeutic Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Asia-Pacific Personalized Cell Therapeutic Sales Quantity Market Share by Type (2019-2030)
Figure 54. Asia-Pacific Personalized Cell Therapeutic Sales Quantity Market Share by Application (2019-2030)
Figure 55. Asia-Pacific Personalized Cell Therapeutic Sales Quantity Market Share by Region (2019-2030)
Figure 56. Asia-Pacific Personalized Cell Therapeutic Consumption Value Market Share by Region (2019-2030)
Figure 57. China Personalized Cell Therapeutic Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Japan Personalized Cell Therapeutic Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Korea Personalized Cell Therapeutic Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. India Personalized Cell Therapeutic Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Southeast Asia Personalized Cell Therapeutic Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. Australia Personalized Cell Therapeutic Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. South America Personalized Cell Therapeutic Sales Quantity Market Share by Type (2019-2030)
Figure 64. South America Personalized Cell Therapeutic Sales Quantity Market Share by Application (2019-2030)
Figure 65. South America Personalized Cell Therapeutic Sales Quantity Market Share by Country (2019-2030)
Figure 66. South America Personalized Cell Therapeutic Consumption Value Market Share by Country (2019-2030)
Figure 67. Brazil Personalized Cell Therapeutic Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 68. Argentina Personalized Cell Therapeutic Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Middle East & Africa Personalized Cell Therapeutic Sales Quantity Market Share by Type (2019-2030)
Figure 70. Middle East & Africa Personalized Cell Therapeutic Sales Quantity Market Share by Application (2019-2030)
Figure 71. Middle East & Africa Personalized Cell Therapeutic Sales Quantity Market Share by Region (2019-2030)
Figure 72. Middle East & Africa Personalized Cell Therapeutic Consumption Value Market Share by Region (2019-2030)
Figure 73. Turkey Personalized Cell Therapeutic Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Egypt Personalized Cell Therapeutic Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. Saudi Arabia Personalized Cell Therapeutic Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. South Africa Personalized Cell Therapeutic Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 77. Personalized Cell Therapeutic Market Drivers
Figure 78. Personalized Cell Therapeutic Market Restraints
Figure 79. Personalized Cell Therapeutic Market Trends
Figure 80. Porters Five Forces Analysis
Figure 81. Manufacturing Cost Structure Analysis of Personalized Cell Therapeutic in 2023
Figure 82. Manufacturing Process Analysis of Personalized Cell Therapeutic
Figure 83. Personalized Cell Therapeutic Industrial Chain
Figure 84. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 85. Direct Channel Pros & Cons
Figure 86. Indirect Channel Pros & Cons
Figure 87. Methodology
Figure 88. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
AbbVie Inc Bausch Health Companies Inc Teva Pharmaceutical Industries Ltd Cipla Lupin Sun Pharmaceuticals Industries Ltd Hikma Pharmaceuticals PLC AstraZeneca GSK Plc Pfizer Inc Amneal Pharmaceuticals LLC Alvogen F. Hoffmann-La Roche Ltd Amgen Inc Jazz Pharmaceuticals, Inc Amicus Therapeutics, Inc MeiraGTx Limited Rocket Pharmaceuticals, Inc Gilead Sciences, Inc
Related Reports
17 Feb 2023
Medical Care
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
